New alliance between PSA and SHPA announced

At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...

From the President: PSA at the FIP World Congress in Seville,...

I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...

From the President: For 25 years, accreditation has paved the way

For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.

The pain of uncertainty: Managing pain without codeine

With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...

Overprescribing of psychotropics for adults with autism

Adults on the autism spectrum are often prescribed psychotropic medication to manage behaviour, despite limited evidence to support this practice, a new report has...

Prenatal vitamin D for schizophrenia

The genetic and environmental factors behind schizophrenia are poorly understood, but research is increasingly finding links between maternal vitamin D status and the risk...